The risk of isolated locoregional recurrence after initial treatment was 5.6% among young women diagnosed with breast cancer. This was lower than a previously reported 10-year rate of 8% among all ...
Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose A total of 94 breast cancer patients who underwent mastectomy between 1990 and ...
More than two-thirds of women classified as high-risk for breast cancer recurrence were safely spared chemotherapy after a ...
In young women diagnosed with breast cancer, the risk for isolated locoregional recurrence was relatively low over a median follow-up of a decade and, overall, did not differ significantly by tumor ...
The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their individual risk following chemotherapy and surgery. These are the findings ...
Adjuvant radiation and endocrine therapy significantly reduce locoregional recurrence in early-stage breast cancer post-lumpectomy, especially in low-risk patients. Radiation therapy notably decreases ...
During a median follow-up of 9.0 years (IQR, 6.6-10.9), IBTR occurred in 320 patients (3.6%). The initial model, based on variables from Sanghani et al, achieved a Harrell's C-index of 0.74.
Breast cancer can go away for a while and then show up again. It can also spread to different areas of your body when it comes back. Sometimes, breast cancer returns and spreads to the pleura, the ...
Patients with HER2-positive breast cancer in the FLAMINGO-01 phase 3 clinical trial are seeing a continued reduction in recurrence rates, Greenwich LifeSciences, Inc. has reported. The preliminary ...
The POSITIVE trial assessed the safety of pausing endocrine therapy for pregnancy in HR-positive early breast cancer patients. Breastfeeding did not increase short-term breast cancer recurrence risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results